These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30244022)

  • 1. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.
    Tejeda HA; Bonci A
    Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
    Karkhanis A; Holleran KM; Jones SR
    Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
    Tejeda HA; Shippenberg TS; Henriksson R
    Cell Mol Life Sci; 2012 Mar; 69(6):857-96. PubMed ID: 22002579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?
    Shippenberg TS
    Neuropsychopharmacology; 2009 Jan; 34(1):247. PubMed ID: 19079072
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
    Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
    J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.
    Bazov I; Sarkisyan D; Kononenko O; Watanabe H; Yakovleva T; Hansson AC; Sommer WH; Spanagel R; Bakalkin G
    Mol Neurobiol; 2018 Aug; 55(8):7049-7061. PubMed ID: 29383684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.
    Tejeda HA; Wang H; Flores RJ; Yarur HE
    Handb Exp Pharmacol; 2022; 271():223-253. PubMed ID: 33580392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
    Margolis EB; Karkhanis AN
    Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
    Bruchas MR; Land BB; Chavkin C
    Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
    Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
    Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System.
    Massaly N; Copits BA; Wilson-Poe AR; Hipólito L; Markovic T; Yoon HJ; Liu S; Walicki MC; Bhatti DL; Sirohi S; Klaas A; Walker BM; Neve R; Cahill CM; Shoghi KI; Gereau RW; McCall JG; Al-Hasani R; Bruchas MR; Morón JA
    Neuron; 2019 May; 102(3):564-573.e6. PubMed ID: 30878290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the dynorphin/κ opioid receptor system in anxiety.
    Hang A; Wang YJ; He L; Liu JG
    Acta Pharmacol Sin; 2015 Jul; 36(7):783-90. PubMed ID: 25982631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
    Anderson RI; Becker HC
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity.
    Tejeda HA; Wu J; Kornspun AR; Pignatelli M; Kashtelyan V; Krashes MJ; Lowell BB; Carlezon WA; Bonci A
    Neuron; 2017 Jan; 93(1):147-163. PubMed ID: 28056342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-Opioid receptor signaling and brain reward function.
    Bruijnzeel AW
    Brain Res Rev; 2009 Dec; 62(1):127-46. PubMed ID: 19804796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.
    Clark SD; Abi-Dargham A
    Biol Psychiatry; 2019 Oct; 86(7):502-511. PubMed ID: 31376930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The price of seizure control: dynorphins in interictal and postictal psychosis.
    Bortolato M; Solbrig MV
    Psychiatry Res; 2007 May; 151(1-2):139-43. PubMed ID: 17395273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.